Posted in | News | Biofuels | Biomaterials

DEINOVE Reaches First Milestone in ADEME-Funded DEINOCHEM Green Chemistry Program

DEINOVE, an industrial biotech company developing innovative processes for producing biofuels and bio-based compounds from Deinococcus bacteria, today announced it has reached the first milestone of its DEINOCHEM green chemistry program, funded by the ADEME (French Environment and Energy Management Agency) in the framework of the French government initiative "Investing for the Future".

Consequently, DEINOVE will receive, in early February 2015, approximately one million euros in the form of a repayable advance.

The DEINOCHEM program aims to develop new industrial processes to produce intermediates or specialty chemicals from renewable resources by improving the performance of Deinococcus bacteria. The goal is to offer alternatives to products usually derived from petroleum or extracted from plants with low yields, for perfumeries, cosmetics, food and feed. The first molecules produced are aromatic ingredients, antioxidants and / or high-added value pigments, representing a market of hundreds of millions of dollars worldwide.

Achieving this milestone validates the progress made in the genetic engineering of strains. The modified strains construction flow has multiplied by 10 in less than a year, thus accelerating the production and testing of strains of interest. Also, DEINOVE teams have made progress in identifying limiting enzymes[2] to optimize the production of targeted isoprenoids. The license acquired from the INRA and Genoplante Valor[3] for the key enzyme DXS has contributed to these results.

Source: http://www.deinove.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.